
    
      To evaluate the safety and tolerability of two regimens of Bucillamine 100 mg (900 mg and
      1,800 mg) over seven days of treatment compared with Colchicine 0.6 mg (1.8 mg) in the
      treatment of patients with acute gout flare
    
  